Head Of Australia’s Bone Medical Ousted After Two Years
This article was originally published in PharmAsia News
Executive SummaryAustralia's Bone Medical biopharmaceutical company is losing its managing director of the past two years. Troels Jordansen lost his job in a restructuring of the company's board of directors, to be replaced soon by an unnamed person from the United States. Bone Medical, which concentrates on breakthrough treatments for bone and joint degeneration and related diseases, reported having less than $124,000 in cash at the end of the March quarter. (Click here for more
You may also be interested in...
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker.
US FDA’s latest effort to provide guidance for consumers on pharmacogenomics tests underscores the challenges the agency faces in the absence of a clear regulatory framework for lab-developed tests – and with no easy mechanism to update labels for off-patent drugs.